In a first-of-its-kind fixed dose study, once weekly insulin efsitora alfa leads to A1C reduction similar to daily insulin – Investors | Eli Lilly and Company



In a first-of-its-kind fixed dose study, once weekly insulin efsitora alfa leads to A1C reduction similar to daily insulin  Investors | Eli Lilly and Company



Source link

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *